Aug 4, 2022 04:05PM
Aug 4, 2022 04:05PM
Jul 28, 2022 08:00AM
Jul 28, 2022 08:00AM
May 23, 2022 04:05PM
May 23, 2022 04:05PM
May 23, 2022 04:05PM Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
May 19, 2022 08:01AM
May 19, 2022 08:00AM
May 19, 2022 08:00AM
May 5, 2022 04:05PM
May 5, 2022 04:05PM
Apr 28, 2022 08:00AM
Apr 28, 2022 08:00AM Caladrius Biosciences to Host First Quarter 2022 Financial Results Conference Call on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time
Apr 12, 2022 08:00AM
Apr 12, 2022 08:00AM
Mar 22, 2022 04:09PM
Mar 22, 2022 04:05PM
Mar 22, 2022 04:05PM
Mar 15, 2022 08:00AM
Mar 15, 2022 08:00AM Caladrius Biosciences to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Tuesday, March 22, 2022, at 4:30 p.m. Eastern Time
Mar 1, 2022 08:00AM
Mar 1, 2022 08:00AM
Nov 4, 2021 04:05PM
Nov 4, 2021 04:05PM
Oct 28, 2021 08:00AM
Oct 28, 2021 08:00AM
Sep 1, 2021 08:00AM Caladrius Biosciences Announces Appointment of Kristen K. Buck, M.D., as Chief Medical Officer
Sep 1, 2021 08:00AM
Aug 5, 2021 04:05PM
Aug 5, 2021 04:05PM
Jul 29, 2021 08:00AM
Jul 29, 2021 08:00AM
Jun 22, 2021 08:00AM
Jun 22, 2021 08:00AM Caladrius Biosciences to Assess its CLBS201 CD34+ Cell Therapy in Diabetic Kidney Disease
May 12, 2021 08:00AM
May 12, 2021 08:00AM
May 6, 2021 04:05PM
May 6, 2021 04:05PM
Apr 29, 2021 08:30AM
Apr 29, 2021 08:30AM
Feb 25, 2021 04:05PM Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 25, 2021 04:05PM
Feb 18, 2021 04:05PM
Feb 18, 2021 04:05PM
Feb 17, 2021 01:59PM
Feb 17, 2021 01:59PM
Feb 12, 2021 08:16AM
Feb 12, 2021 08:15AM Caladrius Biosciences, Inc. Announces $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules
Feb 12, 2021 08:15AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All